Lemmens I et al (1997) Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet 6:1177–1183
Article CAS PubMed Google Scholar
Lemos MC, Thakker RV (2008) Multiple endocrine neoplaslia type 1 (MEN 1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 29:22–32
Article CAS PubMed Google Scholar
Thakker RV et al (2012) Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab 97:2990–3011
Article CAS PubMed Google Scholar
Gatta-Cherifi B et al (2012) Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe D’etude Des Tumeurs endocrines database. Eur J Endocrinol/Eur Fed Endocr Soc 166:269–279
Dreijerink KMa, Goudet P, Burgess JR, Valk GD (2014) Breast-Cancer predisposition in multiple endocrine neoplasia type 1. N Engl J Med 371:583–584
Article PubMed PubMed Central Google Scholar
van Leeuwaarde RS et al (2017) MEN1-dependent breast cancer: indication for early screening? Results from the Dutch MEN1 study group. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2016-3690
Vidal A, Iglesias MJ, Fernández B, Fonseca E, Cordido F (2008) Cutaneous lesions associated to multiple endocrine neoplasia syndrome type 1. J Eur Acad Dermatol Venereol 22:835–838
Article CAS PubMed Google Scholar
Darling TN et al (1997) Multiple facial angiofibromas and Collagenomas in patients with multiple endocrine neoplasia type 1. Arch Dermatol 7:853–857
Pack S et al (1998) Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene. J Invest Dermatology 110:438–440
Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7–33
The WHO Classification of Tumours Editorial Board (2020) WHO classification of Tumours Soft tissue and Bone Tumours. IARC Press;, Lyon
Ballinger ML et al (2016) Monogenic and polygenic determinants of sarcoma risk: an international genetic study. Lancet Oncol 17:1261–1271
Verschuur AVD et al (2023) Diagnostic utility of Menin immunohistochemistry in patients with multiple endocrine neoplasia type 1 syndrome. Am J Surg Pathol 47:785–791
Article PubMed PubMed Central Google Scholar
Dreijerink KMA et al (2020) Clear cell chondrosarcoma in Von Hippel-Lindau disease. Fam Cancer 19:41–45
Article CAS PubMed Google Scholar
Duro T, Gonzales KL, Adrenal Liposarcoma (2023) A novel presentation of multiple endocrine neoplasia type 1. AACE Clin Case Rep 9:10–12
Nishimura Y et al (2004) Multiple endocrine neoplasia type 1 with unusual concomitance of various neoplastic disorders. Endocr J 51
Marx S et al (1998) Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann Intern Med 129:484–494
Article CAS PubMed Google Scholar
Gibril F, Venzon DJ, Ojeaburu JV, Bashir S, Jensen RT (2001) Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form. J Clin Endocrinol Metab 86:5282–5293
Article CAS PubMed Google Scholar
Santiago deM, Miranda I et al (2023) Clinical and molecular features of four Brazilian families with multiple endocrine neoplasia type 1. Front Endocrinol (Lausanne) 14
Ishida H, Funaki S, Taniguchi S, Morii E, Shintani Y (2024) Familial multiple endocrine neoplasia type 1 with intrathoracic low-grade fibromyxoid sarcoma. Surg Case Rep 10:16
Article PubMed PubMed Central Google Scholar
Shlien A (2008) Excessive Genomic DNA Copy Number Variation in the Li-Fraumeni Cancer Predisposition Syndrome. National Institutes of Health. http://www.pnas.org/cgi/content/full/
Choi J et al (2021) Integrated mutational landscape analysis of uterine leiomyosarcomas. Proc Natl Acad Sci U S A 118
Fukushima H et al (2022) Cancer predisposition genes in Japanese children with rhabdomyosarcoma. J Hum Genet 67
Mirabello L et al (2020) Frequency of pathogenic germline variants in Cancer-Susceptibility genes in patients with Osteosarcoma. JAMA Oncol 6:724–734
Article PubMed PubMed Central Google Scholar
Svoboda LK et al (2017) Tumorigenicity of ewing sarcoma is critically dependent on the trithorax proteins MLL1 and menin. Oncotarget 8:458–471
Comments (0)